Artemether for severe malaria

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 9, 2014, Pages

  Esu, Ekpereonne ^a   Effa, Emmanuel E ^b   Opie, Oko N ^c   Uwaoma, Amirahobu ^a   Meremikwu, Martin M ^a  

^a UNIVERSITY OF CALABAR   (Nigeria)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c Department of General Studies   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTESUNATE; QUININE; ARTEMISININ DERIVATIVE;

ABSCESS; ADULT; AFRICA; ANEMIA; ANOPHELES; ASIA; CAUSE OF DEATH; CHEST INFECTION; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; CONVULSION; DEATH; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOGLYCEMIA; INJECTION SITE REACTION; MALARIA; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; VOMITING; ADOLESCENT; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; META ANALYSIS; PACIFIC ISLANDS; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADOLESCENT; ADULT; AFRICA; ANTIMALARIALS; ARTEMISININS; ASIA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; OCEANIA; QUININE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84937066388     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010678.pub2     Document Type: Review

References (59)

1. Adam I, Idris HM, Mohamed-Ali AA, Aelbasit, Elbashir MI. Comparison of intramuscular artemether and intravenous quinine in the treatment of Sudanese children with severe falciparum malaria. East African Medical Journal 2002;79(12):621-5.
2. Aguwa CN, Ukwe CV, Adibe MO. A comparative study of quinine and artemether in the treatment of severe malaria in Nigerian children. Tropical Journal of Pharmaceutical Research 2010;9(1):11-7.
3. Tran TH, Day NP, Nguyen HP, Nguyen TH, Tran TH, Pham PL, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. New England Journal of Medicine 1996;335(2):76-83.
4. Huda SN, Shahab T, Ali SM, Afzal K, Khan HM. A comparative clinical trial of artemether and quinine in children with severe malaria. Indian Pediatrics 2003;40(10):939-45.
5. Karbwang J, Sukontason K, Rimchala W, Namsiripongpun W, Tin T, Auprayoon P, et al. Preliminary report: a comparative clinical trial of artemether and quinine in severe falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 1992;23(4):768-72.
6. Karbwang J, Tin T, Rimchala W, Sukontason K, Namsiripongpun V, Thanavibul A, et al. Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(6):668-71.
7. Minta D, Sissoko M, Sidibe I, Dolo A, Poudiougou B, Dembele M, et al. Efficacy and safety of artemether in the treatment of severe and complicated malaria in Mali [Efficacite et tolerance de l'artemether dans le traitement du paludisme grave et complique au Mali]. Mali Médical 2005;20(1-2):28-32.
8. Murphy S, English M, Waruiru C, Mwangi I, Amukoye E, Crawley J, et al. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Transactions of the Royal Society of Tropical Medicine and Hygiene 1996;90(3):298-301.
9. Ojuawo A, Adegboye AR, Oyewalo O. Clinical response and parasite clearance in childhood cerebral malaria: A comparison between intramuscular artemether and intravenous quinine. East African Medical Journal 1998;75:450-2.
10. Olumese PE, Björkman A, Gbadegesin RA, Adeyemo AA, Walker O. Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Tropica 1999;73(3):231-6.
11. Osonuga O, Osonuga AA, Osonuga IO, Osonuga A. Temperature changes in the course of treatment of severe malaria patients with artemether and quinine. Asian Journal of Medical Sciences 2011;2(1):41-5.
12. Osonuga OA, Osonuga AA, Osonuga IO, Osonuga A. Comparison of Coma Resolution Time in the Course of Treating Childrenwith Severe Falciparum Malaria with Quinine and Artemether. World Journal of Medical Sciences 2011;6(2):42-45.
13. Osonuga OA, Osonuga IO. Parasitaemia changes in the course of treatment of severe malaria patients with artemether and quinine (A preliminary study). Macedonian Journal of Medical Sciences 2009;2(4):319-23.
14. Phu NH, Tuan PQ, Day N, Mai NT, Chau TT, Chuong LV, et al. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malaria Journal 2010;9:97.
15. Satti GM, Elhassan SH, Ibrahim SA. The efficacy of artemether versus quinine in the treatment of cerebral malaria. Journal of the Egyptian Society of Parasitology 2002;32(2):611-23.
16. Seaton RA, Trevett AJ, Wembri JP, Nwokolo N, Naraqi S, Black J, et al. Randomized comparison of intramuscular artemether and intravenous quinine in adult, Melanesian patients with severe or complicated, Plasmodium falciparum malaria in Papua New Guinea. Annals of Tropical Medicine and Parasitology 1998;92(2):133-9.
17. Taylor TE, Wills BA, Courval JM, Molyneux ME. Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria. Tropical Medicine and International Health 1998;3(1):3-8.
18. van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. New England Journal of Medicine 1996;335(2):69-75.
19. Ha V, Nguyen NH, Tran TB, Bui MC, Nguyen HP, Tran TH, et al. Severe and complicated malaria treated with artemisinin, artesunate or artemether in Viet Nam. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91(4):465-7.
20. Walker O, Salako LA, Omukhodion SI, Sowunmi A. An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993;87(5):564-6.
21. Aceng JR, Byarugaba JS, Tumwine JK. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. British Medical Journal 2005;330(7487):334.
22. Bhattacharya PC, Pai-dhungat AJ, Patel K. Artemether in moderate to severe malaria: a multicenter trial in India. Southeast Asian Journal of Tropical Medicine and Public Health 1997;28(4):736-40.
23. Bunnag D, Karbwang J, Harinasuta T. Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 1992;23(4):762-7.
24. Dunyo S, Sirugo G, Sesay S, Bisseye C, Njie F, Adiamoh M, et al. Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. PLoS One 2011;6(6):e17371.
25. Falade CO, Fadero FF, Happi CT, Dada-Adegbola HO, Gbotosho GO, Ayede I, et al. Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemether followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian children. American Journal of Tropical Medicine and Hygiene 2007;76(1):1-6.
26. Fargier JJ, Louis FJ, Duparc S, Hounsinou C, Ringwald P, Danis M. Comparative study of artemether and quinine in severe Plasmodium falciparum malaria in adults and older children in Cameroon. Médicine Tropicale 1999;59(2):151-6.
27. Karbwang J, Na-Bangchang K, Wattanakoon Y, Thanavibul A, Harinasuta T. Artemether 5 versus 7 day regimen for severe falciparum malaria. Southeast Asian Journal ofTropical Medicine and Public Health 1994;25(4):702-6.
28. Karunajeewa HA, Reeder J, Lorry K, Dabod E, Hamzah J, Page-Sharp M, et al. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea. Antimicrobial Agents and Chemotherapy 2006;50(3):968-74.
29. Pe Than Myint, Tin Shwe. A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987;81(4):559-61.
30. Osonuga OA, Osonuga IO, Akinsomisoye OS, Raji Y, Ademowo OG. Packed cell volume changes in the treatment of severe malarial patients with artemether and quinine (a preliminary study). Journal of Medical Sciences 2006;6(5):853-7.
31. Rehman HU, Bilal H, Ali Q. Comparative study of intramuscular artemether and intravenous quinine in the treatment of cerebral malaria in children. Pakistan Paediatric Journal 2012;36(2):75-80.
32. Rehman MU, Shrestha B, Zehri T, Thapa S. Efficacy of quinine versus artemether in the treatment of severe malaria. Journal of the Nepal Health Research Council 2013;11(23):17-21.
33. Tin Shwe, Pe Than Myint, Ye Htut, Win Myint, Lin Soe. The effect of mefloquine artemether compared with quinine on patients with complicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 1988;82(5):665-6.
34. Shwe T, Hla KK. The effect of artemether plus mefloquine on Myanmar patients with complicated falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 1992;23(Suppl 4):117-21.
35. White NJ, Waller D, Crawley J, Nosten F, Chapman D, Brewster D, et al. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet 1992;339(8789):317-21.
36. Danis M, Chandenier J, Doumbo O, Kombila M, Kouame J, Louis F, et al. Results obtained with i.m. artemether versus i.v. quinine in the treatment of severe malaria in a multi-centre study in Africa. Japan Journal of Tropical Medicine and Hygiene 1996;24(Suppl 1):93-6.
37. Faiz MA, Rahman E, Hossain MA, Rahman MR, Yunus EB, Samad R, et al. A randomized controlled trial comparing artemether and quinine in the treatment of cerebral malaria in Bangladesh. Indian Journal of Malariology 2001;38(1-2):9-18.
38. Artemether-Quinine Meta-analysis Study Group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001;95(6):637-50.
39. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366(9487):717-25.
40. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010;376(9753):1647-57.
41. Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clinical Microbiology Reviews 2009;22(1):13-36.
42. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal 2008;336(7650):924-6.
43. Hien TT, Davis TM, Chuong LV, Ilett KF, Sinh DX, Phu NH, et al. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrobial Agents and Chemotherapy 2004;48(2):871.
44. Ilett KF, Batty KT, Powell SM, Binh TQ, Thu le TA, Phuong HL, et al. The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria. British Journal of Clinical Pharmacology 2002;53(1):23-30.
45. Jaffar S, Van Hensbroek M, Palmer A, Schneider G, Greenwood B. Predictors of a fatal outcome following childhood cerebral malaria. American Journal of TropicalMedicine and Hygiene 1997;57(1):20-4.
46. Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A. Pharmacokinetics and bioavailability of oral and intramuscular artemether. European Journal of Clinical Pharmacology 1997;52(4):307-10.
47. Kyu HH, Fernández E. Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review. Bulletin of the World Health Organization 2009;87(12):896-904.
48. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
49. McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000527]
50. Mithwani S, Aarons L, Kokwaro GO, Majid O, Muchohi S, Edwards G, et al. Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria. British Journal of Clinical Pharmacology 2004;57(2):146-52.
51. Murphy SA, Mberu E, Muhia D, English M, Crawley J, Waruiru C, et al. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91(3):331-4.
52. Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P. Pharmacokinetics of artemisinin-type compounds. Clinical Pharmacokinetics 2000;39(4):255-70.
53. Nealon C, Dzeing A, Müller-Römer U, Planche T, Sinou V, Kombila M, et al. Intramuscular bioavailability and clinical efficacy of artesunate in Gabonese children with severe malaria. Antimicrobial Agents and Chemotherapy 2002;46(12):3933-39.
54. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
55. Sinclair D, Donegan S, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD005967.pub3]
56. ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Experimental Parasitology 1993;76(1):85-95.
57. World Health Organization. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000;94(Suppl 1):S1-90.
58. World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization, 2008.
59. World Health Organization. Roll Back Malaria Department. Guidelines for the treatment of malaria. Second Edition. Geneva: World Health Organization, 2010.